Effects of vitamin D optimization on quality of life of patients with fibromyalgia: A randomized controlled trial
- PMID: 30159280
- PMCID: PMC6108287
- DOI: 10.14196/mjiri.32.29
Effects of vitamin D optimization on quality of life of patients with fibromyalgia: A randomized controlled trial
Abstract
Background: Numerous studies have been conducted to evaluate the frequency of hypovitaminosis D in patients with fibromyalgia syndrome (FMS) and its association with FMS symptoms. This study aimed at assessing the effect of hypovitaminosis D on the symptoms and quality of life of patients with fibromyalgia. Methods: A total of 74 FMS patients with hypovitaminosis D were randomly assigned into group A (Trazodone 25 mg at bedtime + vitamin D 50 000 IU weekly) and group B (Trazodone 25 mg at bedtime + placebo). Serum vitamin D level, Widespread Pain Index (WPI), Fibromyalgia Impact Questionnaire (FIQ), Pittsburgh Sleep Quality Index (PSQI), and Short Form Health Survey (SF-36) were used at the beginning of the treatment and 4 and 8 weeks post treatment. Results: Significant improvements were observed in WPI, FIQ, and PSQI scores in both groups. Moreover, combination of vitamin D and Trazodone resulted in significant improvement of SF-36 scores compared to Trazodone therapy. Improvement in pain-related indices including the WPI and the physical component score (PCS) fraction of SF-36 was more noticeable in vitamin D/Trazodone combination therapy. Conclusion: This study suggests that vitamin D supplementation has significant therapeutic benefits in the management of FMS, especially in pain reduction of patients with fibromyalgia. According to our results, a combination of vitamin D supplements and a conventional antidepressant, when given to vitamin D-deficient fibromyalgia patients, could significantly improve both physical and psychological symptoms.
Keywords: Fibromyalgia syndrome; Pain; Quality of life; Vitamin D.
References
-
- Wolfe F. Fibromyalgia. Prognosis in the Rheumatic Diseases: Springer; 1991. p. 321-32.
-
- Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum. 1995;38(1):19–28. - PubMed
-
- Burckhardt CS, Clark S, Bennett RR. Fibromyalgia and quality of life. J Rheumtol. 1993;20(3):475–9. - PubMed
-
- Armstrong D, Meenagh G, Bickle I, Lee A, Curran E-S, Finch M. Vitamin D deficiency is associated with anxiety and depression in fibromyalgia. Clin Rheumatol. 2007;26(4):551–4. - PubMed
-
- Wepner F, Scheuer R, Schuetz-Wieser B, Machacek P, Pieler-Bruha E, Cross HS. et al. Effects of vitamin D on patients with fibromyalgia syndrome: a randomized placebo-controlled trial. PAIN. 2014;155(2):261–8. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous